Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Clinicopathologic features of late-onset veno-occlusive disease/sinusoidal obstruction syndrome after high dose intravenous busulfan and hematopoietic cell transplant.

Pai RK, van Besien K, Hart J, Artz AS, O'Donnell PH.

Leuk Lymphoma. 2012 Aug;53(8):1552-7. doi: 10.3109/10428194.2012.661052. Epub 2012 Mar 13.

2.

Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease.

O'Donnell PH, Artz AS, Undevia SD, Pai RK, Del Cerro P, Horowitz S, Godley LA, Hart J, Innocenti F, Larson RA, Odenike OM, Stock W, Van Besien K.

Leuk Lymphoma. 2010 Dec;51(12):2240-9. doi: 10.3109/10428194.2010.520773. Epub 2010 Oct 4.

3.

BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.

Dignan FL, Wynn RF, Hadzic N, Karani J, Quaglia A, Pagliuca A, Veys P, Potter MN; Haemato-oncology Task Force of British Committee for Standards in Haematology; British Society for Blood and Marrow Transplantation.

Br J Haematol. 2013 Nov;163(4):444-57. doi: 10.1111/bjh.12558. Epub 2013 Sep 17.

PMID:
24102514
4.

Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.

Carreras E, Rosiñol L, Terol MJ, Alegre A, de Arriba F, García-Laraña J, Bello JL, García R, León A, Martínez R, Peñarrubia MJ, Poderós C, Ribas P, Ribera JM, San Miguel J, Bladé J, Lahuerta JJ; Spanish Myeloma Group/PETHEMA.

Biol Blood Marrow Transplant. 2007 Dec;13(12):1448-54.

5.

Severe veno-occlusive disease/sinusoidal obstruction syndrome after deceased-donor and living-donor liver transplantation.

Takamura H, Nakanuma S, Hayashi H, Tajima H, Kakinoki K, Kitahara M, Sakai S, Makino I, Nakagawara H, Miyashita T, Okamoto K, Nakamura K, Oyama K, Inokuchi M, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Onishi I, Kayahara M, Tani T, Arai K, Yamashita T, Yamashita T, Kitamura H, Ikeda H, Kaneko S, Nakanuma Y, Matsui O, Ohta T.

Transplant Proc. 2014 Dec;46(10):3523-35. doi: 10.1016/j.transproceed.2014.09.110.

PMID:
25498084
6.
7.

Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children.

Qureshi A, Marshall L, Lancaster D.

Pediatr Blood Cancer. 2008 Apr;50(4):831-2. doi: 10.1002/pbc.21425.

PMID:
18286502
8.

Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation.

Toh HC, McAfee SL, Sackstein R, Cox BF, Colby C, Spitzer TR.

Bone Marrow Transplant. 1999 Oct;24(8):891-5.

9.

Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome.

Lee JL, Gooley T, Bensinger W, Schiffman K, McDonald GB.

Biol Blood Marrow Transplant. 1999;5(5):306-15.

10.

Hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation in adult patients with idiopathic aplastic anemia.

Kim H, Lee KH, Sohn SK, Jung CW, Joo YD, Kim SH, Kim BS, Choi JH, Kwak JY, Kim MK, Bae SH, Shin HJ, Won JH, Oh S, Lee WS, Park JH, Yoon SS.

Leuk Res. 2013 Oct;37(10):1241-7. doi: 10.1016/j.leukres.2013.06.024. Epub 2013 Jul 18.

PMID:
23871157
11.

Significance of isolated hepatic veno-occlusive disease/sinusoidal obstruction syndrome after liver transplantation.

Sebagh M, Azoulay D, Roche B, Hoti E, Karam V, Teicher E, Bonhomme-Faivre L, Saliba F, Duclos-Vallée JC, Samuel D.

Liver Transpl. 2011 Jul;17(7):798-808. doi: 10.1002/lt.22282.

12.
13.

How I treat sinusoidal obstruction syndrome.

Chao N.

Blood. 2014 Jun 26;123(26):4023-6. doi: 10.1182/blood-2014-03-551630. Epub 2014 May 15.

14.

Hepatic veno-occlusive disease--liver toxicity syndrome after bone marrow transplantation.

Shulman HM, Hinterberger W.

Bone Marrow Transplant. 1992 Sep;10(3):197-214. Review.

PMID:
1422475
15.

High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients.

Myers KC, Lawrence J, Marsh RA, Davies SM, Jodele S.

Biol Blood Marrow Transplant. 2013 Mar;19(3):500-3. doi: 10.1016/j.bbmt.2012.11.011. Epub 2012 Dec 1.

16.

[Low dose heparin for the prevention of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation].

Chen J, Zhu KE, Zhang T, Zhong J, Chen ST, Zeng HL.

Zhonghua Nei Ke Za Zhi. 2007 Feb;46(2):140-2. Chinese.

PMID:
17445443
17.

Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Risk Factors and Stratification, Prophylaxis, and Treatment.

Dalle JH, Giralt SA.

Biol Blood Marrow Transplant. 2016 Mar;22(3):400-9. doi: 10.1016/j.bbmt.2015.09.024. Epub 2015 Oct 23. Review.

PMID:
26431626
18.

Thrombosis in stem cell transplantation.

Kansu E.

Hematology. 2012 Apr;17 Suppl 1:S159-62. doi: 10.1179/102453312X13336169156735.

PMID:
22507809
19.

Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors.

Hasegawa S, Horibe K, Kawabe T, Kato K, Kojima S, Matsuyama T, Hirabayashi N.

Bone Marrow Transplant. 1998 Dec;22(12):1191-7.

20.

Veno-occlusive disease of the liver in the absence of elevation in bilirubin in pediatric patients after hematopoietic stem cell transplantation.

Myers KC, Dandoy C, El-Bietar J, Davies SM, Jodele S.

Biol Blood Marrow Transplant. 2015 Feb;21(2):379-81. doi: 10.1016/j.bbmt.2014.09.026. Epub 2014 Oct 6.

Items per page

Supplemental Content

Write to the Help Desk